Alternative Data for Exact Sciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 315 | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 719,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1,375 | Sign up | Sign up | Sign up |
| Facebook Followers | 11,616 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 11,194 | Sign up | Sign up | Sign up |
| X Followers | 6,613 | Sign up | Sign up | Sign up |
| X Mentions | 8 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 57 | Sign up | Sign up | Sign up |
| Linkedin Employees | 6,266 | Sign up | Sign up | Sign up |
About Exact Sciences
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers.
| Price | $103.57 |
| Target Price | Sign up |
| Volume | 3,185,469 |
| Market Cap | $19.8B |
| Year Range | $40.91 - $103.71 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
'Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal' - BloombergFebruary 22 - Benzinga |
|
Exact Sciences Stockholders Voted To Approve Proposed Acquisition By AbbottFebruary 20 - Benzinga |
|
 |
Exact Sciences reports Q4 EPS (45c) vs (27c) last yearFebruary 13 - Thefly.com |
 |
Exact Sciences Earnings Review: Q4 SummaryFebruary 13 - Benzinga |
Exact Sciences Q4 Adj. EPS $(0.21) Misses $(0.07) Estimate, Sales $878.381M Beat $860.895M EstimateFebruary 13 - Benzinga |
|
 |
Exact Sciences (EXAS): Buy, Sell, or Hold Post Q3 Earnings?February 8 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 851M | 267M | 584M | -20M | 38M | 0.240 |
| Q2 '25 | 811M | 249M | 562M | -1.2M | 53M | -0.010 |
| Q1 '25 | 707M | 206M | 501M | -101M | -38M | -0.358 |
| Q4 '24 | 713M | 284M | 429M | -865M | -815M | -0.240 |
| Q3 '24 | 709M | 196M | 513M | -38M | 26M | -0.210 |
Insider Transactions View All
| Herriott James filed to sell 11,585 shares at $70. November 21 '25 |
| ORVILLE JACOB A filed to sell 23,237 shares at $75. November 21 '25 |
| Baranick Brian filed to sell 22,368 shares at $70.1. November 6 '25 |
| Herriott James filed to sell 12,585 shares at $70.1. November 6 '25 |
| Zanotti Katherine S filed to sell 60,759 shares at $65. October 27 '25 |
Similar companies
Read more about Exact Sciences (EXAS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Exact Sciences
The Market Cap of Exact Sciences is $19.8B.
Currently, the price of one share of Exact Sciences stock is $103.57.
The EXAS stock price chart above provides a comprehensive visual representation of Exact Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Exact Sciences shares. Our platform offers an up-to-date EXAS stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Exact Sciences (EXAS) does not offer dividends to its shareholders. Investors interested in Exact Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Exact Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
